C12Y 116/03
Oxidoreductases oxidizing metal ions: with oxygen as acceptor
Official title: with oxygen as acceptor (1.16.3)
C12Y116/03 (Oxidoreductases oxidizing metal ions: with oxygen as acceptor) appears on 34 US grants and 74 published applications in this corpus.
Search patents in C12Y- Granted patents
- 34
- Published applications
- 74
- Assignees
- 38
- Inventors
- 60
- Latest grant
- 2 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2002 | 0 | 1 |
| 2003 | 1 | 3 |
| 2004 | 1 | 0 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 0 | 0 |
| 2008 | 0 | 0 |
| 2009 | 0 | 0 |
| 2010 | 0 | 0 |
| 2011 | 0 | 0 |
| 2012 | 0 | 0 |
| 2013 | 0 | 5 |
| 2014 | 2 | 28 |
| 2015 | 11 | 2 |
| 2016 | 2 | 4 |
| 2017 | 2 | 3 |
| 2018 | 1 | 4 |
| 2019 | 3 | 2 |
| 2020 | 3 | 5 |
| 2021 | 1 | 4 |
| 2022 | 0 | 3 |
| 2023 | 4 | 3 |
| 2024 | 0 | 1 |
| 2025 | 2 | 5 |
| 2026 | 1 | 1 |
By publication year. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Genetically encoded fluorescent-iron ferritin nanoparticle probes for detecting an intracellular target by fluorescent and electron microscopy2 Jun 2026US 12,643,929 B2The Salk Institute for Biological Studies
- Methods for screening host cells expressing target proteins15 Apr 2025US 12,275,953 B2Industrial Technology Research Institute
- Adeno-associated virus variant capsids and methods of use thereof11 Feb 2025US 12,221,616 B2AD Molecular Therapeutics Inc.
- Adeno-associated virus variant capsids and methods of use thereof12 Dec 2023US 11,840,704 B24D Molecular Therapeutics Inc.
- Bioavailable dithiocarbamate-metal complex particles, method of preparation and use thereof26 Sep 2023US 11,766,404 B2Palacky University Olomouc
- In vivo production of proteins25 Jun 2026US 2026/0174909 A1ModernaTX, Inc.
- Methods of determining ceruloplasmin activity and applications thereof4 Dec 2025US 2025/0369031 A1Academia Sinica
- Adeno-associated virus variant capsids and methods of use thereof22 May 2025US 2025/0163469 A14D Molecular Therapeutics Inc.
- Methods and pharmaceutical compositions for the treatment and the prevention of cardiomyopathy due to energy failure3 Apr 2025US 2025/0109407 A1Assistance Publique-HôPitaux De Paris (Aphp)
- Methods and pharmaceutical composition for the treatment and the prevention of cardiomyopathy due to energy failure3 Apr 2025US 2025/0109408 A1
Most cited
By later US patents
- Modified polynucleotides for the production of biologics and proteins associated with human disease196US 8,999,380 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating protein deficiency194US 9,061,059 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding copper metabolism (MURR1) domain containing 1124US 9,095,552 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides encoding citeD4124US 9,114,113 B2Moderna Therapeutics, Inc. · 2015
- Modified polynucleotides for treating galactosylceramidase protein deficiency121US 9,089,604 B2Moderna Therapeutics, Inc. · 2015